Alternative therapeutic strategy for existing aortic aneurysms using mesenchymal stem cell–derived exosomes

References

• Global Health Care Exchange GBD Result Tool [Internet]. 2017. Seattle (WA): Institute for Health Metrics and Evaluation; [cited 2018 Nov 2]. Available from: http://ghdx.healthdata.org/gbd-results-tool
   Google Scholar
• Harky A, Chan JSK, Wong CHM, et al. Current challenges in open versus endovascular repair of ruptured thoracic aortic aneurysm. J Vasc Surg. 2018;68:1582–1592.
   PubMed Web of Science ®Google Scholar
• Daye D, Walker TG. Complications of endovascular aneurysm repair of the thoracic and abdominal aorta: evaluation and management. Cardiovasc Diagn Ther. 2018;8:S138–S156.
   PubMed Web of Science ®Google Scholar
• Lederle FA, Wilson SE, Johnson GR, et al. Immediate Repair Compared with Surveillance of Small Abdominal Aortic Aneurysms. N Engl J Med. 2002;346:1437–1444.
   PubMed Web of Science ®Google Scholar
• Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2019;16:225–242.
   PubMed Web of Science ®Google Scholar
• Anidjar S, Dobrin PB, Eichorst M, et al. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg. 1992;16:139–147.
   PubMed Web of Science ®Google Scholar
• Hendel A, Ang LS, Granville DJ. Inflammaging and proteases in abdominal aortic aneurysm. Curr Vasc Pharmacol. 2015;13:95–110.
   PubMed Web of Science ®Google Scholar
• Rabkin SW. The Role Matrix Metalloproteinases in the Production of Aortic Aneurysm. Prog Mol Biol Transl Sci. 2017;147:239–265.
   PubMed Web of Science ®Google Scholar
• Eagleton MJ. Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles. Vascular. 2012;20:278–283.
   PubMed Web of Science ®Google Scholar
• Parekkadan B, Milwid JM. Mesenchymal Stem Cells as Therapeutics. Annu Rev Biomed Eng. 2010;12:87–117.
   PubMed Web of Science ®Google Scholar
• Galipeau J, Sensébé L. Mesenchymal Stromal Cells: clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018;22:824–833.
   PubMed Web of Science ®Google Scholar
• Rezaie J, Mehranjani MS, Rahbarghazi R, et al. Angiogenic and Restorative Abilities of Human Mesenchymal Stem Cells Were Reduced Following Treatment With Serum From Diabetes Mellitus Type 2 Patients. J Cell Biochem. 2018;119:524–535.
   PubMed Web of Science ®Google Scholar
• Fu X, Yamawaki-Ogata A, and Oshima H, et al. Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse. J Transl Med. 2013;11:1.•• One of our previous studies. Multiple intravenous administrations of BM-MSCs attenuated the development of AT II induced AA in apoE−/− mice.
   PubMed Web of Science ®Google Scholar
• Yamawaki-ogata A, Fu X, and Hashizume R, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells in formed aortic aneurysms of a mouse model. Eur J Cardio Thoracic Surg. 2014;45:1–10.•• One of our previous studies. It demonstrated that BM-MSCs might be an effective treatment for AAs.
   PubMed Web of Science ®Google Scholar
• Nikfarjam S, Rezaie J, Zolbanin NM, et al. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med. 2020;18:1–21.
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:1–60.
   Web of Science ®Google Scholar
• Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011;6:481–492.
   PubMed Web of Science ®Google Scholar
• Gatti S, Bruno S, Deregibus MC, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011;26:1474–1483.
   PubMed Web of Science ®Google Scholar
• Lai RC, Yeo RWY, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82–88.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Pittenger MF. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells. 2017;35:851–858.
   PubMed Web of Science ®Google Scholar
• Kordelas L, Rebmann V, Ludwig A-K, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28:970–973.
   PubMed Web of Science ®Google Scholar
• Hashizume R, Yamawaki-Ogata A, Ueda Y, et al. Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice. J Vasc Surg. 2011;54:1743–1752.
   PubMed Web of Science ®Google Scholar
• Jones JA, Beck C, Barbour JR, et al. Alterations in aortic cellular constituents during thoracic aortic aneurysm development: myofibroblast-mediated vascular remodeling. Am J Pathol. 2009;175:1746–1756.
   PubMed Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425–6440.
   PubMed Web of Science ®Google Scholar
• Folco EJ, Rocha VZ, López-Ilasaca M, et al. Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10. J Biol Chem. 2009;284:25569–25575.
   PubMed Web of Science ®Google Scholar
• Williams AC, Smartt H, Zadeh AM, et al. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-κB. Cell Death Differ. 2007;14:137–145.
   PubMed Web of Science ®Google Scholar
• Batten M, Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med. 2007;85:661–672.
   PubMed Web of Science ®Google Scholar
• Tang W, Lu Y, Tian Q-Y, et al. The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice. Science. 2011;332:478–484.
   PubMed Web of Science ®Google Scholar
• Taggart CC, Cryan S-A, Weldon S, et al. Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding. J Exp Med. 2005;202:1659–1668.
   PubMed Web of Science ®Google Scholar
• Rothuizen TC, Kemp R, Duijs JMGJ, et al. Promoting Tropoelastin Expression in Arterial and Venous Vascular Smooth Muscle Cells and Fibroblasts for Vascular Tissue Engineering. Tissue Eng Part C Methods. 2016;22:923–931.
   PubMed Web of Science ®Google Scholar
• Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs. 1997;15:61–75.
   PubMed Web of Science ®Google Scholar
• Spinosa M, Lu G, and Su G, et al. Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147. FASEB J. 2018;32:6038–6050.• As far as we know, this is the first published study demonstrated that MSC-dereived extracellular vesicles attenuate aortic aneurysm formation.
   Web of Science ®Google Scholar
• Baglio SR, Rooijers K, Koppers-Lalic D, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015;6:127.
   PubMed Web of Science ®Google Scholar
• Welten SMJ, Goossens EAC, Quax PHA, et al. The multifactorial nature of microRNAs in vascular remodelling. Cardiovasc Res. 2016;110:6–22.
   PubMed Web of Science ®Google Scholar
• Jakob P, Landmesser U. Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res. 2012;93:614–622.
   PubMed Web of Science ®Google Scholar
• Fu X, Zhou Y, Cheng Z, et al. MicroRNAs: novel Players in Aortic Aneurysm. Biomed Res Int. 2015;2015:1–9.
   Web of Science ®Google Scholar
• Kunter U, Rong S, Boor P, et al. Mesenchymal Stem Cells Prevent Progressive Experimental Renal Failure but Maldifferentiate into Glomerular Adipocytes. J Am Soc Nephrol. 2007;18:1754–1764.
   PubMed Web of Science ®Google Scholar
• Thirabanjasak D, Tantiwongse K, Thorner PS. Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy. J Am Soc Nephrol. 2010;21:1218–1222.
   PubMed Web of Science ®Google Scholar
• Furlani D, Ugurlucan M, Ong LL, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77. 370–376.
   PubMed Web of Science ®Google Scholar
• Xin H, Wang F, Li Y, et al. Secondary Release of Exosomes from Astrocytes Contributes to the Increase in Neural Plasticity and Improvement of Functional Recovery after Stroke in Rats Treated with Exosomes Harvested from MicroRNA 133b-Overexpressing Multipotent Mesenchymal Stromal Ce. Cell Transplant. 2017;26:243–257.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;1:7.
   Google Scholar
• Zhang Q, Fu L, Liang Y, et al. Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation. J Cell Physiol. 2018;233:6832–6840.
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Rezaie J. Ageing and mesenchymal stem cells derived exosomes: molecular insight and challenges. Cell Biochem Funct. 2021;39:60–66.
   PubMed Web of Science ®Google Scholar